» Articles » PMID: 30373891

The Evasive Enemy: Insights into the Virulence and Epidemiology of the Emerging Attaching and Effacing Pathogen

Overview
Journal Infect Immun
Date 2018 Oct 31
PMID 30373891
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The diarrheic attaching and effacing (A/E) pathogen was first isolated from infants in Bangladesh in 1991, although the bacterium was initially classified as Subsequent genetic and biochemical interrogation of these isolates raised concerns about their initial taxonomic placement. It was not until 2003 that these isolates were reassigned to the novel taxon because they were genetically more closely related to , although they had diverged sufficiently to warrant a novel species name. Unfortunately, new isolates continue to be mistyped as enteropathogenic (EPEC) or enterohemorrhagic (EHEC) owing to shared traits, most notably the ability to form A/E lesions. Consequently, remains an underappreciated A/E pathogen, despite multiple reports demonstrating that many provisional EPEC and EHEC isolates incriminated in disease outbreaks are actually Metagenomic studies on dozens of isolates reveal a genetic architecture that boasts an arsenal of candidate virulence factors to rival that of its better-characterized cousins, EPEC and EHEC. Beyond these computational comparisons, studies addressing the regulation, structure, function, and mechanism of action of its repertoire of virulence factors are lacking. Thus, the paucity of knowledge about the epidemiology, virulence, and antibiotic resistance of , coupled with its misclassification and its ability to develop multidrug resistance in a single step, highlights the challenges in combating this emerging pathogen. This review seeks to synthesize our current but incomplete understanding of the biology of .

Citing Articles

Isolation and Detection of the Emerging Pathogen in Clinical Stool Samples and the Potential Transmission by Meat Samples in Retail.

Zafar M, De Rauw K, Van den Abeele A, Joossens M, Heyvaert L, Houf K Microorganisms. 2025; 12(12.

PMID: 39770611 PMC: 11677093. DOI: 10.3390/microorganisms12122408.


Protective effect of gut microbiota restored by fecal microbiota transplantation in a sepsis model in juvenile mice.

Han Y, Kim S, Shin H, Kim H, Park J Front Immunol. 2024; 15:1451356.

PMID: 39502702 PMC: 11534669. DOI: 10.3389/fimmu.2024.1451356.


Phenotypic diversity of type III secretion system activity in enteropathogenic clinical isolates.

Contreras C, Hazen T, Guadarrama C, Cervantes-Rivera R, Ochoa T, Vinuesa P J Med Microbiol. 2024; 73(10).

PMID: 39432330 PMC: 11493143. DOI: 10.1099/jmm.0.001907.


Genetic distribution, characterization, and function of type III secretion system 2 (ETT2).

Wang X, Zhu H, Hu J, Zhang B, Guo W, Wang Z iScience. 2024; 27(5):109763.

PMID: 38706860 PMC: 11068852. DOI: 10.1016/j.isci.2024.109763.


Analysis of changes in bacterial diversity in healthy and bacterial wilt mulberry samples using metagenomic sequencing and culture-dependent approaches.

Yuan T, Qazi I, Li J, Yang P, Yang H, Zhang X Front Plant Sci. 2023; 14:1206691.

PMID: 37680359 PMC: 10481342. DOI: 10.3389/fpls.2023.1206691.


References
1.
Kenny B, DeVinney R, Stein M, Reinscheid D, Frey E, Finlay B . Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell. 1997; 91(4):511-20. DOI: 10.1016/s0092-8674(00)80437-7. View

2.
Mills E, Baruch K, Charpentier X, Kobi S, Rosenshine I . Real-time analysis of effector translocation by the type III secretion system of enteropathogenic Escherichia coli. Cell Host Microbe. 2008; 3(2):104-13. DOI: 10.1016/j.chom.2007.11.007. View

3.
Lai L, Wainwright L, Stone K, Donnenberg M . A third secreted protein that is encoded by the enteropathogenic Escherichia coli pathogenicity island is required for transduction of signals and for attaching and effacing activities in host cells. Infect Immun. 1997; 65(6):2211-7. PMC: 175305. DOI: 10.1128/iai.65.6.2211-2217.1997. View

4.
Asoshima N, Matsuda M, Shigemura K, Honda M, Yoshida H, Oda T . Isolation of Escherichia albertii from Raw Chicken Liver in Fukuoka City, Japan. Jpn J Infect Dis. 2015; 68(3):248-50. DOI: 10.7883/yoken.JJID.2014.530. View

5.
Fuller C, Pellino C, Flagler M, Strasser J, Weiss A . Shiga toxin subtypes display dramatic differences in potency. Infect Immun. 2011; 79(3):1329-37. PMC: 3067513. DOI: 10.1128/IAI.01182-10. View